Liu et al. [23] developed a four‐gene signature (AGRN, AKR1A1, DDIT4, and HMMR) related to glycolysis to predict the lung adenocarcinoma patient outcomes that showed desirable accuracy. This evidence concerns the gene AGRN and lung adenocarcinoma.